SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant volatility and trending downward after investors reacted negatively to conservative guidance and ongoing concerns about soft sales in China, despite the company posting a double earnings beat. The community is deeply divided, with many retail investors labeling the brand as 'stale' or 'woke' while others view the depressed price as a generational buying opportunity for a long-term turnaround.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for community discussions as it faces significant price volatility and touches new lows, prompting intense debate between long-term "hodlers" maintaining conviction in its technology and skeptics questioning the project's viability. Market sentiment is heavily divided between those seeking bargain entry points based on institutional partnerships and those exiting due to concerns over management, staff reductions, and stagnant network activity compared to broader crypto sector performance.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF (NASA) is drawing significant attention as traders debate whether its small asset base and exposure to SpaceX represent a promising new momentum play or a potential risk. Community discussion is sharply divided, with some investors eyeing the ticker for its high-volatility potential and similarities to recent thematic ETF surges, while others express skepticism over its low assets under management and limited holdings.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors digest the commercial launch of Yartemlea following recent FDA approval and look ahead to upcoming earnings for initial revenue insights. Community discussion remains focused on the company's strong cash position, the strategic potential of the Novo Nordisk partnership, and anticipation of a potential squeeze as market participants weigh long-term value against ongoing short interest.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is seeing intense community debate as investors weigh its status as a battle-tested DeFi protocol against significant price volatility and concerns over governance efficacy. While some holders point to a capped supply and potential for V4 protocol updates as a catalyst for a rebound, many participants are expressing frustration over persistent downward pressure and are actively comparing its performance to competitors like AAVE.

Ganymede

Ganymede is gaining traction as community members highlight its stable price structure and deliberate accumulation phase as indicators of potential upward momentum. Investors are actively discussing the token's steady progression and disciplined market behavior, viewing the current setup as an opportunity to build positions before further volatility.

Inflection Point Acquisition Corp. IV is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Andrew Stephen Gundlach and Michel Combes on June 24, 2024 and is headquartered in New York, NY.

Merlin Inc.

Merlin Inc. is trending as investors digest the appointment of a new Chief Marketing Officer, viewed by many as a signal for scaling operations and strengthening the company's brand in the autonomous aviation sector. Community discussion is heavily focused on the company's long-term potential as a first-mover in AI flight technology and its strategic defense contracts, while some participants remain cautious, debating the valuation and the timeline for broad regulatory certification.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is currently drawing significant attention from investors ahead of its earnings report, with the community polarized between those betting on long-term institutional growth through AI-driven insurance tech and those skeptical of its operational efficiency and membership retention. Conversations remain heavily focused on the company's ability to achieve profitability in 2026, the potential impact of ACA policy shifts, and whether the stock's recent price volatility represents a buying opportunity or a deeper structural decline.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom is currently at the center of intense debate among retail traders who are vocally frustrated by stagnant price action and perceived market manipulation, while technical analysts closely monitor critical support levels and potential gap-fill opportunities following the company's recent product developments. The community is actively debating whether the stock is an oversold buying opportunity poised for a technical bounce or a fundamental value trap facing continued institutional selling pressure.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh recent strategic growth initiatives, including new commercialization partnerships in the metabolic and obesity drug space, against broader concerns regarding patent cliffs and shifting demand in its core vaccine segment. The community is actively discussing the stock's long-term potential as a dividend-paying value play while closely monitoring its oncology pipeline and speculative M&A sentiment within the biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Viavi Solutions (NASDAQ:VIAV) Trading Down 7.1%  - Time to Sell?

Viavi Solutions (NASDAQ:VIAV) Stock Price Down 7.1% - Here's Why...

Thompson Investment Management Inc. Sells 77,643 Shares of Viavi Solutions Inc. $VIAV

Thompson Investment Management Inc. decreased its holdings in shares of Viavi Solutions Inc. (NASDAQ:VIAV - Free Report) by 17.2% during the 4th quarter, according to the company in its most recent...

Viavi Solutions Inc. $VIAV Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. raised its holdings in shares of Viavi Solutions Inc. (NASDAQ:VIAV - Free Report) by 59.8% in the 4th quarter, according to the company in its most recent disclosure...

Viavi Solutions Inc. (NASDAQ:VIAV) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Viavi Solutions Inc. (NASDAQ:VIAV - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nine ratings firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold r...

Viavi Solutions (NASDAQ:VIAV) Reaches New 1-Year High  - Should You Buy?

Viavi Solutions (NASDAQ:VIAV) Sets New 12-Month High - Here's Why...

Billion-Dollar Opportunity Emerges for RF Sensing Technologies in Offshore Exploration

Billion-Dollar Opportunity Emerges for RF Sensing Technologies in Offshore Exploration Billion-Dollar Opportunity Emerges for RF Sensing Technologies in Offshore Exploration PR Newswire NEW YORK...

AIA Group Ltd Invests $1.44 Million in Viavi Solutions Inc. $VIAV

AIA Group Ltd bought a new position in shares of Viavi Solutions Inc. (NASDAQ:VIAV - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and...

Viavi Solutions (NASDAQ:VIAV) Trading Down 8%  - Should You Sell?

Viavi Solutions (NASDAQ:VIAV) Shares Down 8% - Here's Why...

Lumentum (LITE) Surges 7.9%: Is This an Indication of Further Gains?

Lumentum (LITE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Viavi Solutions (NASDAQ:VIAV) Shares Up 5.1% After Analyst Upgrade

Viavi Solutions (NASDAQ:VIAV) Stock Price Up 5.1% After Analyst Upgrade...

Viavi Solutions, Inc. engages in the provision of network test, monitoring, and assurance solutions for communications service providers, enterprises, network equipment manufacturers, government and avionics. It operates through the following segments: Network and Service Enablement, and Optical Security and Performance. The Network and Service Enablement segment provides an integrated portfolio of testing, monitoring, assurance and security solutions to help build, maintain and optimize telecom and datacom networks. The Optical Security and Performance segment leverages its core optical coating technologies and volume manufacturing capability to design, manufacture and sell technologies for the anti-counterfeiting, 3D sensing, government and aerospace, automotive and industrial markets. The company was founded in 1979 and is headquartered in Chandler, AZ.

Viavi Solutions Inc

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

VIAV
Viavi Solutions Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VIAV News

VIAVViavi Solutions Inc